2nd-Ever Post-Grant Review Ends In Settlement

Loeb & Loeb partner Mark Waddell is a named as counsel for Roche Palo Alto LLC in connection with a settlement reached between Accord Healthcare Inc. and drugmakers Roche and Helsinn Healthcare SA. over a patent on nausea drug Aloxi, ending the second-ever post-grant review proceeding under the America Invents Act.

Click here to read the article on the Law360 website.